Search

Ann M Hsu

from New York, NY
Age ~60
Get Report
Also known as:
Ann Mei Hua Hsu, Meihua H Hsu, Mei H Hsu, Ann M H Wang, Ann M Su, Ann M Cheng, A Hsu, Mei Su, Mei Hua, Anne Mei-Hua Hsu
Related to:
Ashley Beck, 48Michael Y Chan, 54Chih M Chen, 73Sheri Chen, 71Kuang-Hua Hsu, 57Sarah A Chen, 45
Connected to:
Agnes Hsu, 49Alain Hsu, 70Allen Hsu, 37Amber B Hsu, 48Ami K Hsu, 57Anne Hsu, 36Anton N Hsu, 28Anya Hsu, 28Bailey Hsu, 46Bailing Hsu, 62

Ann Hsu Phones & Addresses

  • New York, NY
  • Cedar Park, TX
  • Yorktown Heights, NY
  • North Castle, NY
  • 340 Auburn Way APT 19, San Jose, CA 95129
  • Redwood City, CA
  • Pasadena, CA
  • Palo Alto, CA
  • 218 Morning Star Dr, San Jose, CA 95131

Specialities

Real Estate

Professional Records

Lawyers & Attorneys

Ann Hsu Photo 1

Ann Hsu - Lawyer

View page
Specialties:
Real Estate
ISLN:
919096347
Admitted:
2006
University:
Emory University, M.A., 2003; Oglethorpe University, B.A., 2000; School of Oriental and African Studies, University of London, M.S., 2002
Law School:
University of Texas School of Law, J.D., 2006

Resumes

Resumes

Ann Hsu Photo 2

Pbjs Account Director

View page
Location:
Greater New York City Area
Industry:
Marketing and Advertising
Ann Hsu Photo 3

Ann Hsu

View page
Ann Hsu Photo 4

Ann Hsu

View page
Ann Hsu Photo 5

Counselor

View page
Industry:
Mental Health Care
Work:
Howe Stidger's Counseling Services
Counselor
Ann Hsu Photo 6

Ann Hsu

View page
Ann Hsu Photo 7

Ann Hsu

View page
Location:
United States
Ann Hsu Photo 8

Ann Hsu

View page
Location:
United States
Ann Hsu Photo 9

Ann Hsu

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ann Hsu
Manager
Hypertech Inc
Computer Software · Whol Computers/Peripherals Ret Computers/Software
279 Central Ave APT B, Metuchen, NJ 08840
PO Box 4582, Metuchen, NJ 08840
(732) 635-1755, (732) 635-1756
Ann Hsu
CHINA FOR THE CONNOISSEUR, INC
345 E 56 St #6F, New York, NY 10022
215 Bermuda Dr Neshanic Sta, Neshanic Station, NJ 08853

Publications

Us Patents

Pharmaceutical Dosage Forms Having Immediate Release And/Or Controlled Release Properties

View page
US Patent:
8007827, Aug 30, 2011
Filed:
Sep 30, 2005
Appl. No.:
11/239249
Inventors:
Larry Hsu - Los Altos Hills CA, US
Ann F. Hsu - Los Altos Hills CA, US
Assignee:
Impax Laboratories, Inc. - Hayward CA
International Classification:
A61K 9/22
US Classification:
424468, 424400, 424457, 424489
Abstract:
The present invention relates generally to pharmaceutical dosage forms comprising: an absorption window active agent; a controlled release component comprising enteric-coated controlled release beads, wherein the enteric-coated release beads comprise at least two pH-sensitive polymer layers. The controlled-release dosage forms provide good bioavailability of absorption window active agents.

Controlled Release Formulations Of Levodopa And Uses Thereof

View page
US Patent:
8377474, Feb 19, 2013
Filed:
Dec 26, 2008
Appl. No.:
12/599668
Inventors:
Ann Hsu - Los Altos Hills CA, US
Jim H. Kou - San Jose CA, US
Laman Alani - Hillsborough CA, US
Assignee:
Impax Laboratories, Inc. - Hayward CA
International Classification:
A61K 9/26
A61K 9/24
US Classification:
424470, 424472
Abstract:
The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.

Controlled Release Formulations Of Levodopa And Uses Thereof

View page
US Patent:
8454998, Jun 4, 2013
Filed:
Feb 6, 2012
Appl. No.:
13/367230
Inventors:
Ann Hsu - Los Altos Hills CA, US
Jim H. Kou - San Jose CA, US
Laman Alani - Hillsborough CA, US
Assignee:
Impax Laboratories, Inc. - Hayward CA
International Classification:
A61K 9/26
A61K 9/24
US Classification:
424470, 424472
Abstract:
The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.

Controlled Release Formulations Of Levodopa And Uses Thereof

View page
US Patent:
8557283, Oct 15, 2013
Filed:
Dec 11, 2012
Appl. No.:
13/711248
Inventors:
Ann Hsu - Los Altos Hills CA, US
Jim H. Kou - San Jose CA, US
Laman Lynn Alani - Fort Worth TX, US
Assignee:
Impax Laboratories, Inc. - Hayward CA
International Classification:
A61K 9/26
A61K 9/24
US Classification:
424470, 424472
Abstract:
The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.

Pharmaceutical Dosage Forms Having Immediate And Controlled Release Properties That Contain An Aromatic Amino Acid Decarboxylase Inhibitor And Levodopa

View page
US Patent:
20040166159, Aug 26, 2004
Filed:
Feb 27, 2004
Appl. No.:
10/787417
Inventors:
Ann Hsu - Los Altos Hills CA, US
Larry Hsu - Los Altos Hills CA, US
International Classification:
A61K031/198
A61K009/22
US Classification:
424/468000, 514/567000
Abstract:
The present invention relates generally to pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase (AAAD) inhibitor (such as carbidopa), levodopa, and optionally a cathecol-O-methyltransferase (COMT) inhibitor, for the treatment of medical conditions associated with reduced dopamine levels in a patient's brain.

Oral Disintegrating Dosage Forms

View page
US Patent:
20050147670, Jul 7, 2005
Filed:
Dec 30, 2004
Appl. No.:
11/025013
Inventors:
Ann Hsu - Los Altos Hills CA, US
Assignee:
IMPAX Laboratories Inc. - Hayward CA
International Classification:
A61K031/198
A61K031/137
B27N003/00
US Classification:
424464000, 514567000, 514649000, 264109000
Abstract:
The invention is directed to pharmaceutical dosage forms having immediate release via rapid oral disintegration, specifically, orally disintegrating tablets containing levodopa and carbidopa. The invention further provides formulations containing relatively increased amounts of carbidopa than previously available, including, for example, formulations containing carbidopa-levodopa ratios of about 1:1 to about 1:3.

Pharmaceutical Dosage Forms Having Controlled Release Properties That Contain A Gabab Receptor Agonist

View page
US Patent:
20050220863, Oct 6, 2005
Filed:
Apr 2, 2004
Appl. No.:
10/815924
Inventors:
Ann Hsu - Los Altos Hills CA, US
Larry Hsu - Los Altos Hills CA, US
Charles Hsiao - Pleasanton CA, US
Ching-Ling Teng - Fremont CA, US
International Classification:
A61K009/00
A61K009/48
A61K009/22
US Classification:
424451000, 424468000
Abstract:
The present invention relates generally to pharmaceutical dosage forms having immediate release and controlled release properties that contain a γ-aminobutyric acid (GABA) receptor agonist, e.g., baclofen, for the treatment of medical conditions, which includes spasms, cramping, and tightness of muscles, associated with ailments such as multiple sclerosis or certain spinal injuries.

Pharmaceutical Dosage Forms Having Controlled Release Properties That Contain A Gabab Receptor Agonist

View page
US Patent:
20050220864, Oct 6, 2005
Filed:
Apr 2, 2004
Appl. No.:
10/815929
Inventors:
Ann Hsu - Los Altos Hills CA, US
Larry Hsu - Los Altos Hills CA, US
Charles Hsiao - Pleasanton CA, US
Ching-Ling Teng - Fremont CA, US
International Classification:
A61K031/495
A61K009/48
A61K009/22
US Classification:
424451000, 424468000
Abstract:
The present invention relates generally to pharmaceutical dosage forms having controlled release properties that contain a γ-aminobutyric acid (GABA) receptor agonist, e.g., baclofen, for the treatment of medical conditions, which includes spasms, cramping, and tightness of muscles, associated with ailments such as multiple sclerosis or certain spinal injuries.
Control profile
Ann M Hsu from New York, NY, age ~60 Get Report